Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 08, 2018

SELL
$16.77 - $24.71 $607,040 - $894,452
-36,198 Closed
0 $0
Q1 2018

May 02, 2018

SELL
$16.68 - $22.07 $44,485 - $58,860
-2,667 Reduced 6.86%
36,198 $619,000
Q4 2017

Feb 09, 2018

SELL
$11.23 - $19.1 $571,831 - $972,572
-50,920 Reduced 56.71%
38,865 $736,000
Q3 2017

Nov 03, 2017

BUY
$15.41 - $32.17 $210,469 - $439,377
13,658 Added 17.94%
89,785 $1.58 Million
Q2 2017

Aug 11, 2017

BUY
N/A
76,127
76,127 $2.53 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track F Dx Advisors, Inc. Portfolio

Follow F Dx Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.